Pressure Ulcers Treatment Market Regional Analysis

Pressure Ulcers Treatment Market size was valued at USD 6.1 Billion in 2023 and is poised to grow from USD 6.42 Billion in 2024 to USD 9.99 Billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

Mergers, acquisitions and collaborations are some of the strategies adopted and implemented by the key players to increase their geographical foothold. Moreover, these businesses have gained immense traction owing to forward integration and emphasizing more on value chain. 'Smith & Nephew plc (UK) ', '3M Healthcare (US) ', 'Molnlycke Health Care AB (Sweden) ', 'Coloplast A/S (Denmark) ', 'ConvaTec Group plc (UK) ', 'Integra LifeSciences (US) ', 'Medtronic plc (Ireland) ', 'Cardinal Health, Inc. (US) ', 'B. Braun Melsungen AG (Germany) ', 'Paul Hartmann AG (Germany) ', 'Acelity L.P. Inc. (US) ', 'Derma Sciences, Inc. (US) ', 'Organogenesis Inc. (US) ', 'Hollister Incorporated (US) ', 'Medline Industries, Inc. (US) ', 'Coloplast Corp. (US) ', 'BSN Medical GmbH (Germany) ', 'Lohmann & Rauscher GmbH & Co. KG (Germany) ', 'Systagenix Wound Management, Ltd. (UK)'

Factors that will expand the pressure ulcer treatment market include an increase in the number of patients with pressure ulcers, rising healthcare expenditure, an increase in the geriatric population, an increase in the adoption of artificial skin substitutes, rising government funding, and rising initiatives by government and private organisations to raise awareness about the negative impact of pressure ulcers on patient health and quality of life.

Increasing use of polyurethane foam dressings: Polyurethane foam dressings, which are semipermeable, are used to treat wounds. Foam dressings come in adhesive and non-adhesive varieties, and they can be used for leg ulcers, surgical and infected wounds, burns, abrasions, and lacerations.

In recent years, the pressure ulcer treatment market has evolved at a rapid pace, with companies adapting to changing technological trends in developed regions. North America and Europe accounted for 60% of the market in 2021 and are expected to maintain this share during the forecast period. Increasing investments by market leaders in these regions, as well as clinical trials and pilot tests, are helping to expand the pressure ulcer treatment market in these regions.